If you’ve ever stared at the ceiling at 2 a.m., mind racing, you know how desperate insomnia can feel. It’s no surprise that millions of people turn to sleep medications — they’re fast, accessible, and offer the immediate promise of relief. But if you’ve been relying on Ambien, Lunesta, Benadryl, or even over-the-counter melatonin to get through the night, there’s something important you should know: these medications do not treat insomnia. They mask it.
As a clinical psychologist practicing in La Jolla and San Diego, I specialize in Cognitive Behavioral Therapy for Insomnia — known as CBT-I — a structured, evidence-based treatment developed by researchers at Harvard Medical School, most notably Dr. Gregg Jacobs. CBT-I has been shown in large clinical trials to outperform sleep medications in both the short and long term. And unlike medications, CBT-I produces lasting results by addressing the actual causes of chronic insomnia.
This post will explain why sleep medications fall short, what CBT-I involves, and how Dr. Jacobs’ protocol — the foundation of my approach — can help you reclaim restorative sleep without a pill bottle on your nightstand.
The Problem with Sleep Medications
They Don’t Treat the Underlying Cause
Chronic insomnia is maintained by a set of maladaptive thoughts, behaviors, and physiological patterns that develop over time. Things like spending excessive time in bed hoping sleep will come, catastrophizing about the consequences of a bad night, irregular sleep schedules, and conditioned arousal — the phenomenon where your bedroom itself becomes a trigger for wakefulness rather than sleep.
Sleep medications do nothing to address any of these drivers. They induce sedation, which is not the same as natural, restorative sleep. When you stop taking them, the insomnia returns — often worse than before, a phenomenon known as rebound insomnia.
The Evidence on Long-Term Efficacy Is Weak
Most prescription sleep medications are approved for short-term use — typically two to four weeks — because that’s the window for which evidence of efficacy exists. Yet studies consistently show that insomnia patients use these medications for months or years. Long-term use is associated with tolerance (needing more for the same effect), dependence, cognitive side effects including memory impairment, increased fall risk — particularly in older adults — and suppression of slow-wave and REM sleep, which are the most restorative sleep stages.
A landmark 2004 meta-analysis published in JAMA found that CBT-I produced larger improvements in sleep onset latency and sleep efficiency than pharmacotherapy, and that these gains were maintained at follow-up while medication effects were not.
They Can Make the Problem Worse Over Time
One of the most clinically significant issues with sleep medications is that they reinforce a passive approach to insomnia. Rather than building confidence in the body’s natural sleep capacity, they create reliance on an external agent — and with that reliance comes anxiety. Patients often report heightened sleep anxiety on nights they don’t take their medication, a form of conditioned arousal that perpetuates the very insomnia they’re trying to treat.
CBT-I: The Gold Standard Treatment
Cognitive Behavioral Therapy for Insomnia is a structured, multicomponent intervention typically delivered over six to eight sessions. It was developed and rigorously validated by Dr. Gregg Jacobs at Harvard Medical School and has since been endorsed as the first-line treatment for chronic insomnia by the American College of Physicians, the American Academy of Sleep Medicine, and the National Institutes of Health.
CBT-I works by directly targeting the cognitive and behavioral factors that perpetuate insomnia. It consists of several core components:
Sleep Restriction Therapy
This is often the most counterintuitive — and most powerful — component of CBT-I. Rather than spending more time in bed hoping sleep will happen, patients temporarily restrict their time in bed to match their actual sleep time. This builds sleep pressure (homeostatic drive), consolidates fragmented sleep, and breaks the cycle of lying awake in bed that reinforces conditioned arousal.
It can feel difficult in the first week, but when implemented correctly and guided by a trained clinician, sleep restriction produces rapid and robust improvements. Dr. Jacobs’ protocol emphasizes careful titration of this technique to balance efficacy with tolerability.
Stimulus Control
Stimulus control addresses the conditioned association between the bed and wakefulness. The core principle is simple: the bed should be used only for sleep and sex. No reading, watching television, scrolling, or lying awake ruminating. When patients cannot sleep, they are instructed to get out of bed and return only when sleepy.
Over time, this rebuilds the association between the bed and sleep, reducing the arousal response that keeps so many insomnia sufferers awake the moment they lie down.
Cognitive Restructuring
Chronic insomnia is almost always accompanied by a set of distorted beliefs about sleep — beliefs that amplify arousal and perpetuate the disorder. Common examples include: ‘I must get eight hours or I won’t function,’ ‘I’ve lost the ability to sleep naturally,’ and ‘Lying in bed resting is almost as good as sleep.’
CBT-I uses Socratic questioning and psychoeducation to challenge and replace these beliefs with more accurate, adaptive ones. Dr. Jacobs places particular emphasis on reducing sleep-related anxiety and building confidence in the body’s intrinsic sleep regulatory system — a system that, in most patients with primary insomnia, is fundamentally intact.
Sleep Hygiene and Relaxation Training
While sleep hygiene alone is insufficient to treat chronic insomnia, it forms an important adjunct to the core behavioral components. This includes guidance on caffeine and alcohol timing, bedroom environment, light exposure, and exercise. Relaxation techniques — including diaphragmatic breathing, progressive muscle relaxation, and mindfulness — help reduce the physiological arousal that interferes with sleep onset and maintenance.
What the Research Shows
The evidence base for CBT-I is extensive and consistent. Across dozens of randomized controlled trials and multiple meta-analyses, CBT-I has demonstrated:
- Significant reductions in sleep onset latency (time to fall asleep)
- Significant reductions in wake after sleep onset (nighttime awakenings)
- Improvements in sleep efficiency — the ratio of time asleep to time in bed
- Increased total sleep time
- Improved daytime functioning and quality of life
- Durable effects that persist months and years after treatment ends
In a widely cited study by Jacobs et al. (2004), CBT-I was directly compared to zolpidem (Ambien) in a randomized controlled trial. At post-treatment, both treatments showed improvement, but at the five-week follow-up, patients who received CBT-I showed significantly greater gains — and those gains were maintained. The medication group, by contrast, showed no additional improvement after discontinuation.
This finding is not anomalous. It is the consistent story told by the CBT-I literature: behavioral treatment produces more durable improvements because it addresses causes rather than symptoms.
Who Is CBT-I For?
CBT-I is appropriate for adults with chronic insomnia — defined as difficulty initiating or maintaining sleep at least three nights per week for at least three months, with associated daytime impairment. It is effective regardless of whether insomnia occurs in isolation or comorbidly with depression, anxiety, chronic pain, or other medical conditions.
CBT-I is also appropriate — and often preferable — for patients who are currently using sleep medications and want to reduce or discontinue them. A gradual medication taper can be conducted concurrently with CBT-I, with the behavioral treatment providing a scaffold for sustained sleep improvement as the medication is withdrawn.
The only patients for whom CBT-I may require modification or deferral are those with untreated sleep apnea, certain parasomnias, or acute psychiatric presentations requiring stabilization. A thorough clinical assessment prior to treatment ensures the intervention is appropriately tailored.
Working with a CBT-I Trained Psychologist
While CBT-I digital programs and self-help books exist, working with a trained clinician offers significant advantages. A skilled CBT-I provider can individualize the protocol to your specific pattern of insomnia, titrate sleep restriction safely, help you navigate the initial discomfort of behavioral change, address comorbid psychological factors that may be contributing to sleep disturbance, and monitor progress systematically.
At Pinover Psychology Corporation in La Jolla, I provide CBT-I as a structured, evidence-based treatment grounded in Dr. Jacobs’ Harvard protocol. Sessions are available in person and via telehealth throughout California. If you’ve been managing insomnia with medications — or simply struggling to sleep well — I invite you to reach out for a free 15-minute consultation to discuss whether CBT-I might be the right approach for you.
The Bottom Line
Insomnia is one of the most treatable conditions in behavioral medicine — but only when it’s treated correctly. Sleep medications offer a short-term workaround at the cost of long-term dependence and the perpetuation of the disorder itself. CBT-I, by contrast, teaches you to sleep again by working with your brain’s natural sleep regulatory system rather than overriding it.
The research is unambiguous. The Harvard-developed protocol is effective, durable, and free of the side effects that accompany pharmacological management. If you’re ready to stop treating insomnia with a pill and start actually resolving it, CBT-I is the path forward.
Dr. Michael Pinover, Psy.D. is a licensed clinical psychologist in La Jolla, CA specializing in CBT-I, psychodynamic therapy, and addiction treatment. He offers a free 15-minute consultation for new clients. Contact the practice at (619) 616-7151 or through pinoverpsychology.com/contact-us.
References
Jacobs, G.D., Pace-Schott, E.F., Stickgold, R., & Otto, M.W. (2004). Cognitive behavior therapy and pharmacotherapy for insomnia: A randomized controlled trial and direct comparison. Archives of Internal Medicine, 164(17), 1888-1896.
Morin, C.M., Culbert, J.P., & Schwartz, S.M. (1994). Nonpharmacological interventions for insomnia: A meta-analysis of treatment efficacy. American Journal of Psychiatry, 151(8), 1172-1180.
Qaseem, A., Kansagara, D., Forciea, M.A., Cooke, M., & Denberg, T.D. (2016). Management of chronic insomnia disorder in adults: A clinical practice guideline from the American College of Physicians. Annals of Internal Medicine, 165(2), 125-133.
Meltzer, L.J., & Mindell, J.A. (2014). Systematic review and meta-analysis of behavioral interventions for pediatric insomnia. Journal of Pediatric Psychology, 39(8), 932-948.
Pinover Psychology Corporation | La Jolla, CA 92037 | PSY35712 | pinoverpsychology.com